Cluster of differentiation 30, also TNFSF8, a member of the TNR receptor superfamily. Characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.
Last sync to Obsidian:
30/05/2025, 00:53:28
Cluster of differentiation 30, also TNFSF8, a member of the TNR receptor superfamily. Characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.